⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVLS News
Spinal Muscular Atrophy Market Opportunity Assessment and Forecasts 2023-2033 Spinraza's Expected Patent Expiry Will See Cheap Nusinersen Biosimilars Enter the Market and Reduce Sales
globenewswire.com
NVLS
BHC
Muscular Dystrophy Association Calls FDA Approval of Novartis’ Itvisma (onasemnogene abeparvovec-brve) a Major Step Forward for the Spinal Muscular Atrophy Community
globenewswire.com
NVLS